PL2170104T3 - Kompozycja żywieniowa dla pacjentów z objawami zapowiadającymi otępienie - Google Patents
Kompozycja żywieniowa dla pacjentów z objawami zapowiadającymi otępienieInfo
- Publication number
- PL2170104T3 PL2170104T3 PL08766831T PL08766831T PL2170104T3 PL 2170104 T3 PL2170104 T3 PL 2170104T3 PL 08766831 T PL08766831 T PL 08766831T PL 08766831 T PL08766831 T PL 08766831T PL 2170104 T3 PL2170104 T3 PL 2170104T3
- Authority
- PL
- Poland
- Prior art keywords
- signs
- patients
- nutritional composition
- csf
- predicting dementia
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P20/00—Coating of foodstuffs; Coatings therefor; Making laminated, multi-layered, stuffed or hollow foodstuffs
- A23P20/10—Coating with edible coatings, e.g. with oils or fats
- A23P20/15—Apparatus or processes for coating with liquid or semi-liquid products
- A23P20/18—Apparatus or processes for coating with liquid or semi-liquid products by spray-coating, fluidised-bed coating or coating by casting
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nutrition Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Confectionery (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/NL2007/050310 WO2009002148A1 (en) | 2007-06-27 | 2007-06-27 | Food composition for prodromal dementia patients |
| PCT/NL2008/050408 WO2009002164A1 (en) | 2007-06-27 | 2008-06-20 | Food composition for prodromal dementia patients |
| EP08766831.5A EP2170104B2 (en) | 2007-06-27 | 2008-06-20 | Food composition for prodromal dementia patients |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL2170104T3 true PL2170104T3 (pl) | 2012-02-29 |
| PL2170104T5 PL2170104T5 (pl) | 2025-09-08 |
Family
ID=39085446
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL08766831.5T PL2170104T5 (pl) | 2007-06-27 | 2008-06-20 | Kompozycja żywieniowa dla pacjentów z objawami zapowiadającymi otępienie |
| PL11181091T PL2412250T3 (pl) | 2007-06-27 | 2008-06-20 | Kompozycja żywieniowa dla pacjentów z objawami zapowiadającymi otępienie |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL11181091T PL2412250T3 (pl) | 2007-06-27 | 2008-06-20 | Kompozycja żywieniowa dla pacjentów z objawami zapowiadającymi otępienie |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US8445458B2 (pl) |
| EP (2) | EP2170104B2 (pl) |
| JP (1) | JP5906014B2 (pl) |
| CN (1) | CN101686723A (pl) |
| AT (1) | ATE524077T1 (pl) |
| AU (1) | AU2008269726B2 (pl) |
| BR (1) | BRPI0813912B1 (pl) |
| CA (1) | CA2704906C (pl) |
| DK (1) | DK2412250T3 (pl) |
| ES (2) | ES2551237T3 (pl) |
| FI (1) | FI2170104T4 (pl) |
| HU (1) | HUE028126T2 (pl) |
| IL (1) | IL202967A (pl) |
| MX (1) | MX2009014217A (pl) |
| NZ (1) | NZ582265A (pl) |
| PL (2) | PL2170104T5 (pl) |
| PT (2) | PT2170104E (pl) |
| RU (1) | RU2487557C2 (pl) |
| WO (2) | WO2009002148A1 (pl) |
| ZA (1) | ZA200909227B (pl) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20110104214A1 (en) | 2004-04-15 | 2011-05-05 | Purdue Pharma L.P. | Once-a-day oxycodone formulations |
| WO2009002166A1 (en) | 2007-06-26 | 2008-12-31 | N.V. Nutricia | Improving memory in subjects with mini-mental state examination of 24-26 |
| WO2009002146A1 (en) | 2007-06-26 | 2008-12-31 | N.V. Nutricia | Supporting activities of daily living |
| WO2009002148A1 (en) | 2007-06-27 | 2008-12-31 | N.V. Nutricia | Food composition for prodromal dementia patients |
| WO2009002145A1 (en) | 2007-06-26 | 2008-12-31 | N.V. Nutricia | Lipid composition for improving function of brain functioning |
| BRPI0822111B8 (pt) | 2007-12-20 | 2021-05-25 | Nutricia Nv | composição líquida, e, uso de uma composição líquida |
| EP2806568B1 (en) * | 2008-02-01 | 2015-12-30 | BlackBerry Limited | System and method for uplink timing synchronization in conjunction with discontinuous reception |
| IT1392312B1 (it) * | 2008-12-16 | 2012-02-24 | Pharmarte S R L | Formulazione per la somministrazione vaginale a base di acidi grassi polinsaturi omega-3 e di composti del magnesio. |
| WO2013066151A1 (en) | 2011-10-31 | 2013-05-10 | N.V. Nutricia | Improving recognition |
| US20150044304A1 (en) * | 2011-10-31 | 2015-02-12 | N.V. Nutricia | Composition for improving neuropsychological test battery score |
| WO2013066153A1 (en) | 2011-10-31 | 2013-05-10 | N.V. Nutricia | Composition for improving neuropsychological test battery score |
| WO2013066152A1 (en) * | 2011-10-31 | 2013-05-10 | N.V. Nutricia | Method for improving executive function |
| WO2013129914A1 (en) | 2012-03-02 | 2013-09-06 | N.V. Nutricia | Method for improving functional synaptic connectivity |
| CN104144691A (zh) | 2012-03-02 | 2014-11-12 | N·V·努特里奇亚 | 改善功能突触连通性的方法 |
| WO2013154733A1 (en) * | 2012-04-09 | 2013-10-17 | Hill James W | Protein restriction for disease prevention and treatment |
| US20160136192A1 (en) * | 2013-06-10 | 2016-05-19 | Abbott Laboratories | Methods and compositions for enhancing cognitive performance |
| WO2015115885A1 (en) | 2014-01-31 | 2015-08-06 | N.V. Nutricia | Method for reducing white matter lesions, white matter hyperintensities (wmh), leukoaraiosis or periventricular white matter disease in elderly |
| WO2015115886A1 (en) * | 2014-01-31 | 2015-08-06 | N.V. Nutricia | Method for treating, stabilizing or slowing down brain glucose metabolism deficit |
| GB201405033D0 (en) | 2014-03-20 | 2014-05-07 | Isis Innovation | Combination therapy |
| SG10201808984WA (en) * | 2014-04-14 | 2018-11-29 | Nutricia Nv | Method for assessing and treating or preventing impaired plasma polar lipid levels |
| WO2017069613A1 (en) | 2015-10-23 | 2017-04-27 | N.V. Nutricia | Method for improving recognition and/or working memory in hyperphenylalanimenia and phenylketonuria patients |
| WO2017155386A1 (en) * | 2016-03-08 | 2017-09-14 | N.V. Nutricia | Method for treating brain atrophy |
| WO2017155387A1 (en) | 2016-03-08 | 2017-09-14 | N.V. Nutricia | Method for supporting memory function and/or cognitive function |
| WO2017213490A1 (en) | 2016-06-10 | 2017-12-14 | N.V. Nutricia | Method for controlling neuroinflammation |
| WO2018038599A1 (en) | 2016-08-23 | 2018-03-01 | N.V. Nutricia | Product and method for increasing uridine concentration in blood plasma |
| MX391435B (es) * | 2016-09-29 | 2025-03-21 | Soc Des Produits Nestle S A Star | Acidos grasos omega 3 y colina como neuroprotectores en pacientes sin demencia. |
| CA3054846A1 (en) * | 2017-04-11 | 2018-10-18 | Societe Des Produits Nestle S.A. | Omega-3 fatty acid and vitamin d levels to identify and attenuate cognitive aging in individuals |
| JP6818331B2 (ja) * | 2019-04-24 | 2021-01-20 | 株式会社Hbcフナト | 軽度認知障害を治療又は予防するための組成物 |
| EP4748443A3 (en) * | 2021-09-17 | 2026-08-12 | N.V. Nutricia | Solid composition suitable as a nutritional composition or supplement for animals that suffer from brain related disorders, decline or diseases |
Family Cites Families (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3600197A (en) * | 1968-08-27 | 1971-08-17 | Merck & Co Inc | Flavor enhancing compositions for foods and beverages |
| EP0175468A3 (en) | 1984-08-10 | 1987-07-22 | Sentrachem Limited | Eicosanoids for use in cancer therapy |
| JP2525624B2 (ja) | 1987-09-21 | 1996-08-21 | 雪印乳業株式会社 | 多価不飽和脂肪酸配合育児用粉乳 |
| JPH06237734A (ja) | 1991-11-06 | 1994-08-30 | Sanwa Kagaku Kenkyusho Co Ltd | 機能後退性疾患用食品組成物 |
| JP3576318B2 (ja) | 1996-06-19 | 2004-10-13 | 明治乳業株式会社 | 核酸関連物質含有栄養組成物 |
| JPH10136937A (ja) | 1996-11-08 | 1998-05-26 | Takashi Morita | 脳細胞機能向上、血管細胞強化、身体各細胞機能向上栄養総合食品 |
| ATE221324T1 (de) * | 1996-11-20 | 2002-08-15 | Nutricia Nv | Fette enthaltende ernährungszusammensetzung zur behandlung des stoffwechselssyndroms |
| JP3731983B2 (ja) * | 1997-08-27 | 2006-01-05 | 明治製菓株式会社 | 痴呆犬の夜鳴き改善薬 |
| US8518882B2 (en) | 1998-07-31 | 2013-08-27 | Massachusetts Institute Of Technology | Methods and compositions for ameliorating or inhibiting decline in memory or intelligence or improving same |
| US20070004670A1 (en) * | 1998-07-31 | 2007-01-04 | Richard Wurtman | Compositions containing citicoline, and methods of use thereof |
| FR2787799B1 (fr) * | 1998-12-23 | 2001-03-09 | Rhodia Chimie Sa | Composition comprenant une ecorce inorganique et un noyau comportant au moins un compose polyhydroxyle |
| GB9916536D0 (en) * | 1999-07-14 | 1999-09-15 | Scarista Limited | Nutritional or pharmaceutical compositions |
| EP1090636A1 (en) | 1999-09-13 | 2001-04-11 | Société des Produits Nestlé S.A. | High lipid diet |
| GB9925709D0 (en) | 1999-10-30 | 1999-12-29 | Smithkline Beecham Plc | Composition |
| US6835750B1 (en) * | 2000-05-01 | 2004-12-28 | Accera, Inc. | Use of medium chain triglycerides for the treatment and prevention of alzheimer's disease and other diseases resulting from reduced neuronal metabolism II |
| US7226916B1 (en) | 2000-05-08 | 2007-06-05 | N.V. Nutricia | Preparation for the prevention and/or treatment of vascular disorders |
| NZ528634A (en) | 2001-04-30 | 2005-04-29 | Trommsdorff Gmbh & Co | Pharmaceutically active uridine esters |
| US6942874B2 (en) | 2001-05-25 | 2005-09-13 | Linguagen Corp. | Nucleotide compounds that block the bitter taste of oral compositions |
| EP1285590A1 (en) | 2001-08-08 | 2003-02-26 | Société des Produits Nestlé S.A. | Lipid blends |
| NL1019368C2 (nl) * | 2001-11-14 | 2003-05-20 | Nutricia Nv | Preparaat voor het verbeteren van receptorwerking. |
| US20030114415A1 (en) | 2001-12-14 | 2003-06-19 | Wurtman Richard J. | Compositions and methods for treating and preventing memory impairment using citicoline |
| US20040001817A1 (en) * | 2002-05-14 | 2004-01-01 | Giampapa Vincent C. | Anti-aging nutritional supplement |
| PL1733730T3 (pl) | 2003-10-24 | 2008-12-31 | Nutricia Nv | Oligosacharydy immunomodulujące |
| US7090879B2 (en) * | 2004-03-18 | 2006-08-15 | Abbott Laboratories | Nutritional formula containing select carotenoid combinations |
| EP1750509A4 (en) * | 2004-05-13 | 2010-03-24 | Massachusetts Inst Technology | EFFECTS OF URIDINE ON DOPAMINE RELIEF |
| AU2005285090A1 (en) * | 2004-09-15 | 2006-03-23 | Massachusetts Institute Of Technology | Compositions containing uridine, and methods utilizing same |
| EP1656839A1 (en) | 2004-11-11 | 2006-05-17 | N.V. Nutricia | Nutrition containing lipid blend |
| US20060252775A1 (en) | 2005-05-03 | 2006-11-09 | Henderson Samuel T | Methods for reducing levels of disease associated proteins |
| CA2645645C (en) * | 2005-05-23 | 2015-07-14 | Massachusetts Institute Of Technology | Compositions containing pufa and methods of use thereof |
| WO2007001883A2 (en) | 2005-06-20 | 2007-01-04 | Accera, Inc. | Method to reduce oxidative damage and improve mitochondrial efficiency |
| JP5697293B2 (ja) | 2005-06-30 | 2015-04-08 | サントリーホールディングス株式会社 | 器質的脳障害に起因する高次脳機能の低下に対する改善作用を有する組成物 |
| JP5967855B2 (ja) | 2005-06-30 | 2016-08-10 | サントリーホールディングス株式会社 | 日中活動量の低下および/又はうつ症状の改善作用を有する組成物 |
| KR20130101596A (ko) * | 2005-07-08 | 2013-09-13 | 마텍 바이오싸이언스스 코포레이션 | 치매 및 치매-전단계와 관련된 용태의 치료를 위한 다중불포화 지방산 |
| WO2007058523A1 (en) * | 2005-11-17 | 2007-05-24 | N.V. Nutricia | Composition with docosapentaenoic acid |
| US20070140992A1 (en) * | 2005-12-21 | 2007-06-21 | Lynn Schick | Taste masking of essential oils using a hydrocolloid |
| ATE509624T1 (de) * | 2005-12-23 | 2011-06-15 | Nutricia Nv | Zusammensetzung enthaltend mehrfach ungesättigte fettsäuren, proteine, mangan und/oder molybden und nukleotide/nukleoside, zur behandlung von demenz |
| WO2009002166A1 (en) | 2007-06-26 | 2008-12-31 | N.V. Nutricia | Improving memory in subjects with mini-mental state examination of 24-26 |
| WO2009002148A1 (en) | 2007-06-27 | 2008-12-31 | N.V. Nutricia | Food composition for prodromal dementia patients |
| WO2009002146A1 (en) * | 2007-06-26 | 2008-12-31 | N.V. Nutricia | Supporting activities of daily living |
| WO2009002145A1 (en) | 2007-06-26 | 2008-12-31 | N.V. Nutricia | Lipid composition for improving function of brain functioning |
| BRPI0822111B8 (pt) | 2007-12-20 | 2021-05-25 | Nutricia Nv | composição líquida, e, uso de uma composição líquida |
-
2007
- 2007-06-27 WO PCT/NL2007/050310 patent/WO2009002148A1/en not_active Ceased
-
2008
- 2008-06-20 ES ES11181091.7T patent/ES2551237T3/es active Active
- 2008-06-20 EP EP08766831.5A patent/EP2170104B2/en active Active
- 2008-06-20 PT PT08766831T patent/PT2170104E/pt unknown
- 2008-06-20 FI FIEP08766831.5T patent/FI2170104T4/fi active
- 2008-06-20 PL PL08766831.5T patent/PL2170104T5/pl unknown
- 2008-06-20 MX MX2009014217A patent/MX2009014217A/es active IP Right Grant
- 2008-06-20 ES ES08766831T patent/ES2373001T5/es active Active
- 2008-06-20 DK DK11181091.7T patent/DK2412250T3/en active
- 2008-06-20 JP JP2010514660A patent/JP5906014B2/ja active Active
- 2008-06-20 PT PT111810917T patent/PT2412250E/pt unknown
- 2008-06-20 CN CN200880022198A patent/CN101686723A/zh active Pending
- 2008-06-20 EP EP11181091.7A patent/EP2412250B1/en not_active Revoked
- 2008-06-20 CA CA2704906A patent/CA2704906C/en active Active
- 2008-06-20 PL PL11181091T patent/PL2412250T3/pl unknown
- 2008-06-20 HU HUE11181091A patent/HUE028126T2/en unknown
- 2008-06-20 US US12/666,617 patent/US8445458B2/en active Active
- 2008-06-20 BR BRPI0813912A patent/BRPI0813912B1/pt active IP Right Grant
- 2008-06-20 AT AT08766831T patent/ATE524077T1/de active
- 2008-06-20 RU RU2010102526/13A patent/RU2487557C2/ru active
- 2008-06-20 WO PCT/NL2008/050408 patent/WO2009002164A1/en not_active Ceased
- 2008-06-20 NZ NZ582265A patent/NZ582265A/en unknown
- 2008-06-20 AU AU2008269726A patent/AU2008269726B2/en active Active
-
2009
- 2009-12-23 ZA ZA200909227A patent/ZA200909227B/xx unknown
- 2009-12-24 IL IL202967A patent/IL202967A/en active IP Right Grant
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL2412250T3 (pl) | Kompozycja żywieniowa dla pacjentów z objawami zapowiadającymi otępienie | |
| ATE538665T1 (de) | Lipidzusammensetzung zur verbesserung der hirnfunktion | |
| CO6470839A2 (es) | Composiciones farmacéuticas que contienen epa y un agente cardiovascular y métodos de emplearlas | |
| ECSP077401A (es) | Medicamentos que contienen compuestos de carbonilo y su uso | |
| NO20080855L (no) | Behandling med azetidinon-baserte kolesterol absorpsjonsinhibitorer og omega-3 fettsyrer og et kombinasjonsprodukt derav | |
| BRPI0517462A (pt) | métodos e materiais para conferir resistência a pestes e patógenos de plantas | |
| ATE488517T1 (de) | 3 -amino- imidazo ä1,2-aüpyridinderivate mit sglt1 und sglt2 hemmender wirkung zur behandlung von diabetes vom typ 1 und typ 2 | |
| ATE518432T1 (de) | Herstellung von lebensmittelprodukten mit verbesserter oraler und mentaler erfrischung | |
| EP1899856A4 (en) | PLAYING AND COMPILING MULTIPLE APPLICATIONS IN AN INTERACTIVE MEDIA ENVIRONMENT | |
| GB0514463D0 (en) | Use of pinolenic acid | |
| BRPI1008210A2 (pt) | "emulsão óleo-em-água e produto alimentício que compreende uma emulsão óleo-em-água" | |
| EP1702628A3 (en) | Contrast agents for medical devices | |
| SV2003000712A (es) | Dispositivos y metodos para aplicacion vertida ref. 497363sv:ssi | |
| BRPI0620229A8 (pt) | formulação | |
| UY29236A1 (es) | 2-alcoxi-3,4,5-trihidroxi-alquilamidas. su preparación, composiciones que las contienen y su utilización. | |
| ATE258435T1 (de) | Pinolensäure gegen diabetes | |
| PL2338328T3 (pl) | Pewne rośliny bez nasyconych kwasów tłuszczowych lub ze zmniejszonymi poziomami nasyconych kwasów tłuszczowych w nasionach i olej pochodzący z nasion | |
| DK1863570T3 (da) | Synergistisk varmestabilt oliemedium med eicosapentaensyre (EPA) og decosahexaensyre (DHA) | |
| ITMO20060057A1 (it) | Struttura portante per mobilio, particolarmente per l'arredamento di cucine o simili | |
| Brouillard | Student and faculty perceptions of the causes and solutions to truancy | |
| Hundal | Indian Medical Students' Knowledge and Attitudes about HIV/AIDS | |
| ITBO20060204A1 (it) | Dispositivo per l'apertura di buste contenenti prodotti alimentari o simili. | |
| ITMI20051932A1 (it) | Etichetta per dischi smeriglio o simili ad elevata resistenza contro l'alterazione degli elementi grafici stampati | |
| ITRM20060514A1 (it) | Schermo per la simulazione di stimolazione magnetica transcranica ripetitiva rtms e dispositivo per la somministrazione e la simulazione di rtms provvisto di tale schermo | |
| ITBG20030045A1 (it) | Laminato multistrato da impiegarsi per la realizzazione di materassi e /o simili prodotti. |